COVID-19: mortality rates of patients on hemodialysis and peritoneal dialysisArticle Published on 2022-10-012023-07-08 Journal: International urology and nephrology [Category] COVID19(2023년), [키워드] COVID-19 Maintenance hemodialysis Mortality Peritoneal dialysis SARS-CoV-2 [DOI] 10.1007/s11255-022-03193-6 PMC 바로가기
Safety and immediate humoral response of COVID-19 vaccines in chronic kidney disease patients: the SENCOVAC studyArticle Published on 2022-09-222022-11-15 Journal: Nephrology, dialysis, transplantation : official p [Category] SARS, 진단, [키워드] absence acute respiratory syndrome Adjusted analysis Adverse analysed antibodies antibody Antibody Response baseline BNT162b2 vaccine booster dose chronic Chronic kidney disease CKD cohorts cohorts of patient coronavirus COVID-19 COVID-19 vaccine Day event Factor first dose Haemodialysis humoral Humoral response Isolation Kidney disease kidney transplant measure Most patient mRNA vaccines Odds ratio participant Patient patients Peritoneal dialysis Potential difference recipients reported Safety SARS-CoV-2 second dose severe coronavirus disease Spanish vaccination Vaccine vaccine dose were measured were recorded [DOI] 10.1093/ndt/gfab313 PMC 바로가기
Local and Systemic Immunity Are Impaired in End-Stage-Renal-Disease Patients Treated With Hemodialysis, Peritoneal Dialysis and Kidney Transplant Recipients Immunized With BNT162b2 Pfizer-BioNTech SARS-CoV-2 VaccineBNT162b2 화이자-바이오엔텍 SARS-CoV-2 백신을 접종한 혈액투석, 복막투석, 신장이식 환자 말기 신장질환 환자의 국소 및 전신 면역 손상Article Published on 2022-07-222022-09-12 Journal: Frontiers in Immunology [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] analyzed anti-S anti-S IgG antibodies antibody binding antibody unit BNT162b2 cellular component clinical control group COVID-19 COVID-19 in patient COVID-19 vaccine dose effective End-stage renal disease ESRD Guidance HD group healthy individual Hemodialysis high mortality rate highest IFN-γ IgA IgG Immunity Immunoglobulin G Impaired Interferon-gamma investigated kidney transplant recipient Local Messenger RNA MONITOR mRNA participant Patient patients performed Peritoneal dialysis Pfizer Pfizer-BioNTech positive produced recipient required Research Responder SARS-CoV-2 Seroconversion seroconversion rate seronegative patient seropositive subjects systemic tested therapy Transplant transplantation Trial registration Vaccine vaccine response [DOI] 10.3389/fimmu.2022.832924 PMC 바로가기 [Article Type] Article
Alterations in the molecular composition of COVID-19 patient urine, detected using Raman spectroscopic/computational analysis라만 분광/전산 분석을 사용하여 감지한 COVID-19 환자 소변의 분자 구성 변화Article Published on 2022-07-182022-09-11 Journal: PLoS ONE [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] Abnormalities Accuracy affected alteration Analysis analyzed Bladder cancer Care Chain Reaction Chromatography Clinical pathology collected complex component components computational analysis Contact contact with contributing to correlation correlations COVID-19 COVID-19 disease COVID-19 patient creatinine defined detect determine disease disease severity EGFR elevated fingerprint gas chromatography Gas Chromatography-Mass Spectrometry GC-MS glomerular filtration rate healthy healthy individual healthy individuals Hospitalized HPLC identify in urine include Infection Inflammatory liquid Liquid chromatography Long mass spectrometry metabolomic analysis Mild moderate molecular Negative predictive value pathology Patient patients performance Peritoneal dialysis positive Positive predictive value Predictive value Raman spectroscopy random ranged reaction representing respiratory RT-PCR SARS-CoV-2 virus sensitivity serum creatinine severity specificity specimen specimens Spectrometry Symptom symptomatic tested Urinalysis Urine urine specimens Viral Volunteer with COVID-19 [DOI] 10.1371/journal.pone.0270914 PMC 바로가기 [Article Type] Article
Data on immunogenicity and reactogenicity to COVID-19 vaccination among patients receiving maintenance dialysisData article Published on 2022-06-012022-10-05 Journal: Sensors (Basel, Switzerland) [Category] 변종, [키워드] acute respiratory syndrome assays cellular Cellular immune response Complete coronavirus coronavirus disease COVID-19 COVID-19 vaccination dialysis dose Effectiveness ELISPOT exclusion General population Hemodialysis homologous humoral immune response immune response Immunity immunoassay immunoglobulins increased risk interferon-γ Microparticle morbidity and mortality Patient Peritoneal dialysis produced reactogenicity receiving regimen SARS-CoV-2 SARS-CoV-2 vaccination SARS-CoV-2 vaccine single dose T cells tested the vaccine trials vaccination [DOI] 10.1016/j.dib.2022.108271 [Article Type] Data article
Pandemic affects the uninfected: hypercalcemia in a peritoneal dialysis patient due to protective equipment shortageArticle Published on 2022-06-012023-07-08 Journal: Journal of Nephrology [Category] COVID19(2023년), [키워드] COVID-19 Drywall dust Effects on uninfected Granulomatous lung disease hypercalcemia Peritoneal dialysis PPE shortage [DOI] 10.1007/s40620-022-01272-6 PMC 바로가기
Humoral Response to Third Dose of SARS-CoV-2 Vaccines in the CKD SpectrumArticle Published on 2022-06-012023-07-09 Journal: Clinical journal of the American Society of Nephro [Category] COVID19(2023년), [키워드] Anti-spike Chronic kidney disease COVID-19 Hemodialysis Kidney transplantation Peritoneal dialysis SARS-CoV-2 vaccination [DOI] 10.2215/CJN.01770222
Decreased response to the mRNA anti-SARS-CoV-2 vaccine in hepatitis B vaccine non-responders and frail patients treated with peritoneal dialysis복막투석을 받은 B형 간염 백신 무반응자 및 허약한 환자에서 mRNA anti-SARS-CoV-2 백신에 대한 반응 감소Article Published on 2022-05-252022-09-12 Journal: Nephrology, dialysis, transplantation : official p [Category] MERS, 진단, [키워드] anti-SARS-CoV-2 Decreased hepatitis B mRNA non-responder patients treated Peritoneal dialysis Vaccine [DOI] 10.1093/ndt/gfac031 PMC 바로가기 [Article Type] Article
The clinical features and estimated incidence of MIS-C in Cape Town, South Africa남아프리카 케이프타운에서 MIS-C의 임상적 특징 및 추정 발생률Article Published on 2022-05-022022-09-12 Journal: BMC Pediatrics [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] abdominal pain Affect age Analysis black calculated Cape cardiac children children with MIS-C clinical clinical feature clinical manifestation Coagulation Cohort collected comparison CRP D-dimer deaths demographic data Diagnosis eight Epidemiology ferritin Fever fibrinogen global health Haemoglobin healthy children highlight hospital Hospital stay ICU admission immune incidence independent Infection Inflammatory intravenous invasive ventilation involved lack Logistic regression Low-middle income countries marker median median age Methylprednisolone MIS-C neutrophil count organ system outcome Oxygen therapy paediatrics pandemic performed Peritoneal dialysis Rash recruited renal required SARS-CoV-2 SARS-CoV-2 antibodies serum Seven sodium South Africa Support Surveillance syndrome Tachycardia the healthy town Treatment was tested white cell [DOI] 10.1186/s12887-022-03308-z PMC 바로가기 [Article Type] Article
Effect of Androgen Suppression on Clinical Outcomes in Hospitalized Men With COVID-19: The HITCH Randomized Clinical TrialRandomized Controlled Trial Published on 2022-04-012022-10-04 Journal: JAMA Network Open [Category] COVID19(2023년), SARS, 임상, [키워드] adverse event Affair age all-cause mortality analyzed androgen antiandrogen Antibiotics Asthma baseline cardiovascular disease Care Cell chronic obstructive chronic respiratory clinical Clinical improvement Clinical outcome common Comorbidity convalescent plasma COVID-19 COVID-19 severity Department determine Dexamethasone diabete disease severity disorder double-blind Effect Efficacy end point End points enrolled Hemodialysis hospital Hospitalization Hospitalized hypertension IMPROVE Inpatient interim analysis intravenous fluids Invasive mechanical ventilation mechanical ventilation median men Mortality no difference no significant difference outcome Patient patients patients randomized Peritoneal dialysis Placebo placebo group placebo-controlled primary end point protease randomization Randomized randomized clinical trial reduce expression Remdesivir requiring supplemental oxygen saline placebo SARS-CoV-2 entry secondary Serious Adverse Event severity of COVID-19 Standard standard care stratified subcutaneous dose supplemental oxygen suppression temperature the placebo group therapy TMPRSS2 Trial usual care vasopressor support veteran with COVID-19 [DOI] 10.1001/jamanetworkopen.2022.7852 PMC 바로가기 [Article Type] Randomized Controlled Trial